Browsing Department of Clinical Science by Journals "Vaccines"

Now showing items 1-4 of 4

    • The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium 

      Poulimeneas, Dimitrios; Koniordou, Markela; Kousi, Dimitra; Merakou, Christina; Kopsidas, Ioannis; Tsopela, Grammatiki Christina; Argyropoulos, Christos D.; Themistocleous, Sophia C.; Shiamakkides, George; Constantinou, Marinos; Alexandrou, Alexandra; Noula, Evgenia; Nearchou, Andria; Salmanton-García, Jon; Stewart, Fiona A.; Heringer, Sarah; Albus, Kerstin; Álvarez-Barco, Elena; Macken, Alan; Di Marzo, Romina; Luis, Catarina; Valle-Simón, Paula; Askling, Helena H.; Hellemans, Margot; Spivak, Orly; Davis, Ruth Joanna; Azzini, Anna Maria; Barta, Imre; Součková, Lenka; Jancoriene, Ligita; Akova, Murat; Mallon, Patrick W. G.; Olesen, Ole F.; Frias-Iniesta, Jesus; van Damme, Pierre; Tóth, Krisztina; Cohen-Kandli, Miriam; Cox, Rebecca Jane; Husa, Petr; Nauclér, Pontus; Marques, Laura; Ochando, Jordi; Tacconelli, Evelina; Zeitlinger, Markus; Cornely, Oliver A.; Pana, Zoi Dorothea; Zaoutis, Theoklis E. (Journal article; Peer reviewed, 2023)
      Underserved and hard-to-reach population groups are under-represented in vaccine trials. Thus, we aimed to identify the challenges of vaccine trial participation of these groups in member countries of the VACCELERATE ...

    • Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden 

      Jacob, Jorge; Biering-Sørensen, Tor; Holger Ehlers, Lars; Edwards, Christina Hansen; Mohn, Kristin Greve-Isdahl; Nilsson, Anna; Hjelmgren, Jonas; Ma, Wenkang; Sharma, Yuvraj; Ciglia, Emanuele; Mould-Quevedo, Joaquin (Journal article; Peer reviewed, 2023)
      Individuals aged 65 years and above are at increased risk of complications and death from influenza compared with any other age group. Enhanced vaccines, as the MF59®-adjuvanted quadrivalent influenza vaccine (aQIV) and ...

    • Prospects and challenges in the development of universal influenza vaccines 

      Madsen, Anders; Brokstad, Rebecca Jane Cox (Journal article; Peer reviewed, 2020-07-06)
      Current influenza vaccines offer suboptimal protection and depend on annual reformulation and yearly administration. Vaccine technology has rapidly advanced during the last decade, facilitating development of next-generation ...

    • Responsiveness to influenza vaccination correlates with NKG2C-expression on NK cells 

      Riese, Peggy; Trittel, Stephanie; Pathirana, Rishi; Klawonn, Frank; Cox, Rebecca Jane; Guzmán, Carlos A. (Journal article; Peer reviewed, 2020-06-05)
      Influenza vaccination often results in a large percentage of low responders, especially in high-risk groups. As a first line of defense, natural killer (NK) cells play a crucial role in the fight against infections. However, ...